参考文献/References:
[1]Falck-Ytter Y,Francis CW,Johanson NA,et al.Prevention of VTE in orthopedic surgery patients:antithrombotic therapy and prevention of thrombosis American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(Suppl2):e278S-e325S.
[2]Mont MA,Jacobs JJ,Boggio LN,et al.AAOS Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty[J].Am Acad Orthop Surg,2014,19(12):768-776.
[3]Hamilton WG,Reeves JD,Fricka KB,et al.Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty[J].J Bone Joint Surg,2015,30(1):43-45.
[4]Cherian JJ,Jauregui JJ, Pierce TP,et al.A current review of mechanical compression in venous thromboembolic prophylaxis in total knee and total hip arthroplasty[J].Curropin Rheumatol,2016,15(212):1027-1033.
[5]Perzborn E,Kubitza D,Misselwitz F.Rivaroxaban. A novel, oral, direct factor Xa inhibitor in clinical development for the prevention and reatment of thromboembolic disorders[J].Hamostaseologie,2017,27(4):282-289.
[6]Parvizi J,Huang R,Raphael IJ,et al.Timing of symptomatic pulmonary embolism with warfarin following arthroplasty[J].Arthroplasty,2015,30(6):1050-1053.
[7]Bala A,Huddleston JI,Goodman SB,et al.Venous thromboembolism prophylaxis after TKA: aspirin, warfarin,enoxaparin,or factor Xa inhibitors[J].Clin Orthop Relat Res,2017,475(9):2205-2213.
[8]Mont MA,Jacobs JJ.AAOS clinical practice guideline:preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty[J].Am Acad Orthop Surg,2011,19(12):777-778.
[9]Suen K,Westh RN,Churilov L,et al.Low-molecular-weight heparin and the relative risk of surgical site bleeding complications:results of a systematic review and meta-analysis of randomized controlled trials of venous thromboprophylaxis in patients after total joint arthroplasty[J].Arthroplasty,2017,32(9):2911-2919.
[10]Ricket AL,Stewart DW,Wood RC,et al.Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban or enoxaparin[J].Ann of Pharmacother,2016(50):270-275.
[11]Zou Y,Tian S,Wang Y.Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty[J].Blood Coagul Fibrinolysis,2016(25):660-664.
[12]Parvizi J,Huang R,Restrepo C,et al.Low-dose aspirin is effective chemoprophylaxis gainst clinically important venous thromboembolism following total joint arthroplasty:a preliminary analysis[J].Bone Joint Surg Am,2017,99(2):91-98.
[13]Feldstein MJ,Low SL,Chen AF,et al.Risk factors for venous thromboembolism after total hip and knee replacement surgery[J].Curr Opin Pulm Med,2002(8):365-371.
[14]Ogonda L,Hill J,Doran E,et al.Aspirin for thromboprophylaxis after primary lower limb arthroplasty:early thromboembolic events and 90 day mortality in 11,459 patients[J].Bone Joint,2016,98-B(3):341-348.
[15]Kim YH,Choi IY,Park MR,et al.Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement.A randomized controlled trial[J].Int Orthop,2018(22):6-10.
[16]Huang R,Buckley PS,Scott B,et al.Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection[J].Arthroplasty,2015,30(9Suppl):39-41.
[17]Lassen MR,Raskob GE,Gallus A,et al.Apixaban or enoxaparin for thromboprophylaxis after knee replacement[J].N Engl J Med,2009,361(6):594-604.
[18]Lassen MR,Raskob GE,Gallus A,et al.ADVANCE-2 investigators.Apixaban versus enoxaparin for thromboprophylaxis after knee replacement(ADVANCE-2):a randomised double-blind trial[J].Lancet,2010,375(9717):807-815.
[19]Kakkar AK,Brenner B,Dahl OE,et al.RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty:a double-blind,randomised controlled trial[J].Lancet,2008,372(9632):31-39.
[20]Russell RD,Huo MH.Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty[J].Arthroplasty,2013,28(9):1477-1481.
[21]Eriksson BI,Smith H,Yasothan U,et al.Dabigatran etexilate[J].Nat Rev Drug,2008,7(7):557-558.
[22]Eriksson BI,Dahl OE,Rosencher N,et al.RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial[J].Thromb Haemost,2007,5(11):2178-2185.
[23]Gomez D,Razmjou H,Donovan A,et al.Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery[J].Thromb Haemost,2017(8):678-683.
[24]Charters MA,Frisch NB,Wessell NM,et al.Enoxaparin versus no anticoagulation prophylaxis after total knee arthroplasty in Thai patients: a randomized controlled trial[J].Med Assoc Thai,2017(100):42-49.
[25]Wang JW,Chen B,Lin PC,et al.The efficacy of combined use of rivaroxaban and tranexamic acid on blood conservation in minimally invasive total knee arthroplasty a double-blind randomized, controlled trial[J].Arthroplasty,2017,32(3):801-806.
[26]Garfinkel JH,Gladnick BP,Roland N,et al.Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial[J].Orthop Surg,2018(17):1-5.
[27]Bloch BV,Patel V,Best AJ.Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement[J].Bone Joint,2014,96-B(1):122-126.
[28]Venker BT,Ganti BR,Lin H,et al.Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty:a metaanalysis[J].Arthroplasty,2017,32(2):645-652.
相似文献/References:
[1]梁 钢.造影剂肾病的诊治进展[J].医学信息,2018,31(04):45.[doi:10.3969/j.issn.1006-1959.2018.04.015]
LIANG Gang.Progress in Diagnosis and Treatment of Contrast Nephropathy[J].Journal of Medical Information,2018,31(20):45.[doi:10.3969/j.issn.1006-1959.2018.04.015]
[2]胡少勇,姜浩斌,张景硕,等.3例动脉瘤夹闭术后脑梗塞的手术治疗报告[J].医学信息,2018,31(07):189.[doi:10.3969/j.issn.1006-1959.2018.07.068]
HU Shao-yong,JIANG Hao-bin,ZHANG Jing-shuo,et al.Surgical Treatment of 3 Cases of Cerebral Infarction after Aneurysm Clipping[J].Journal of Medical Information,2018,31(20):189.[doi:10.3969/j.issn.1006-1959.2018.07.068]
[3]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Journal of Medical Information,2018,31(20):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[4]曾凡剑,吴岑江.预防胰十二指肠切除术后胰漏的研究进展[J].医学信息,2018,31(16):30.[doi:10.3969/j.issn.1006-1959.2018.16.009]
ZENG Fan-jian,WU Cen-jiang.Progress in Prevention of Pancreatic Leakage after Pancreaticoduodenectomy[J].Journal of Medical Information,2018,31(20):30.[doi:10.3969/j.issn.1006-1959.2018.16.009]
[5]杜治国,何 龙,黄 进,等.下肢创伤骨折后静脉血栓栓塞症相关检测项目分析[J].医学信息,2019,32(10):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
DU Zhi-guo,HE Long,HUANG Jin,et al.Analysis of Related Items of Venous Thromboembolism after Traumatic Fracture of Lower Extremity[J].Journal of Medical Information,2019,32(20):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
[6]齐尚忠,张 强.低位直肠癌前切除综合征的发病机制及防治研究[J].医学信息,2019,32(20):37.[doi:10.3969/j.issn.1006-1959.2019.20.011]
QI Shang-zhong,ZHANG Qiang.Pathogenesis and Prevention of Low Rectal Cancer Anterior Resection Syndrome[J].Journal of Medical Information,2019,32(20):37.[doi:10.3969/j.issn.1006-1959.2019.20.011]
[7]刘 曼,刘光晶.自体脂肪移植在瘢痕防治中的应用[J].医学信息,2020,33(15):47.[doi:10.3969/j.issn.1006-1959.2020.15.016]
LIU Man,LIU Guang-jing.Application of Autologous Fat Transplantation in Scar Prevention and Treatment[J].Journal of Medical Information,2020,33(20):47.[doi:10.3969/j.issn.1006-1959.2020.15.016]
[8]吴铭洲,顾 磊,远理娟,等.老年髋部骨折患者术后谵妄研究现状[J].医学信息,2020,33(17):30.[doi:10.3969/j.issn.1006-1959.2020.17.009]
WU Ming-zhou,GU Lei,YUAN Li-juan,et al.Research Status of Postoperative Delirium in Elderly Patients with Hip Fracture[J].Journal of Medical Information,2020,33(20):30.[doi:10.3969/j.issn.1006-1959.2020.17.009]
[9]蒙政初,梁世杰,韦金英.中重度痔疮手术后复发原因及对策[J].医学信息,2020,33(20):80.[doi:10.3969/j.issn.1006-1959.2020.20.022]
MENG Zheng-chu,LIANG Shi-jie,WEI Jin-ying.Reasons and Countermeasures for Recurrence of Moderate to Severe Hemorrhoids After Operation[J].Journal of Medical Information,2020,33(20):80.[doi:10.3969/j.issn.1006-1959.2020.20.022]
[10]周伟蓉,莫文娟,杨春菊,等.糖尿病高危足患者参与预防糖尿病足的知识、态度及行为影响因素分析[J].医学信息,2022,35(06):141.[doi:10.3969/j.issn.1006-1959.2022.06.036]
ZHOU Wei-rong,MO Wen-juan,YANG Chun-ju,et al.Analysis on the Influencing Factors of Knowledge, Attitude and Behavior of Diabetic High Risk Foot Patients Participating in the Prevention of Diabetic Foot[J].Journal of Medical Information,2022,35(20):141.[doi:10.3969/j.issn.1006-1959.2022.06.036]